Enstilar
RxNorm concept 1716095, brand name (bn).
- RxCUI
- 1716095
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1716095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- betamethasone dipropionate (PIN, has precise ingredient)
- calcipotriene hydrate (PIN, has precise ingredient)
- betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML [Enstilar] (SBDC, ingredient of)
- betamethasone / calcipotriene Topical Foam [Enstilar] (SBDF, ingredient of)
- Enstilar Topical Product (SBDG, ingredient of)
- betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam [Enstilar] (SBD, ingredient of)
- betamethasone (IN, tradename of)
- calcipotriene (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1716095 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1716095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1716095. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.